Ph. Degen et al., THE INFLUENCE OF FOOD ON THE DISPOSITION OF THE ANTIEPILEPTIC OXCARBAZEPINE AND ITS MAJOR METABOLITES IN HEALTHY-VOLUNTEERS, Biopharmaceutics & drug disposition, 15(6), 1994, pp. 519-526
The effect of food on the pharmacokinetics of the antiepileptic oxcarb
azepine (OXC) was investigated in healthy volunteers. Six healthy male
volunteers were treated with single peroral doses of 600 mg of oxcarb
azepine (Trileptal(R)) after overnight fasting or a fat- and protein-r
ich breakfast. Mean (+/-SD) areas under the plasma concentration-time
curves (AUC) of the major component in plasma, the active monohydroxy
metabolite (MHD), which is responsible for the therapeutic effect in m
an, were 672 (25) mu mol L(-1) h when given to the fasted volunteers a
nd 780 (31) mu mol L(-1) h (p = 0.042) when given after a substantial
breakfast. Mean (+/-SD) maximum concentrations (C-max) were 25.5 (4.8)
mu mol L(-1) when given to the fasted volunteers and 31.4(5.3) mu mol
L(-1) (p = 0.025) when given after breakfast. Thus, the average AUC wa
s increased by 16% and C-max by 23% when oxcarbazepine was given with
food. The times at which C-max was reached (t(max)) as well as the ter
minal half-lives were not influenced by concomitant intake of food. Th
e tolerability was the same whether oxcarbazepine was given before or
after food in healthy volunteers. The slight effect of food on the kin
etics of oxcarbazepine should be of little therapeutic consequence.